[Our preliminary experience in the field of serum prevention of anti-HDN hemolytic disease of the newborn by means of anti-D immunoglobulins].
D001787:Blood Group Incompatibility / Q000628:therapy*; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000628:therapy*; D012204:Rh-Hr Blood-Group System
D007074:Immunoglobulin G; D012204:Rh-Hr Blood-Group System
La nostra esperienza preliminare nel campo della siero profilassi anti-MEN RH con immunoglobuline anti-D